We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Electronic Medical Records Aid Reporting of Drug Problems

By HospiMedica International staff writers
Posted on 01 Dec 2010
Print article
A new study has found that reporting of prescription side effects increases when doctors use computerized patient electronic health records (EHRs).

Researchers at Massachusetts General Hospital (MGH; Boston, USA) and Brigham & Women's Hospital (Boston, MA, USA) conducted a proof-of-concept study of a scalable EHR-based system to automatically send electronic adverse drug events (ADE) reports to the US Food and Drug Administration (FDA) in real time. The study involved 26 clinicians who were given access to EHR-based ADE reporting functionality from December 2008 to May 2009. Outcome measures were the number and content of ADE reports; severity of adverse reactions (clinician and computer algorithm defined); and the results of a clinician survey.

The results showed that the clinicians defined 23% of the ADEs as serious, while a computer algorithm defined only 4% of the ADEs as serious. The most common drug classes were cardiovascular drugs (40%), central nervous system drugs (19%), analgesics (13%), and endocrine drugs (7%). The reports contained information, prefilled from the EHR, about comorbid conditions, concurrent medications, weight, and laboratory data. It took the clinicians a mean of 53 seconds to complete and send the form. Importantly, in the clinician survey, 21 of 23 respondents (91%) said they had submitted zero ADE reports to the FDA in the prior 12 months. The study was published early online on October 11, 2010, in Pharmacoepidemiology and Drug Safety.

"EHR-based, triggered ADE reporting is efficient and acceptable to clinicians, provides detailed clinical information, and has the potential to greatly increase the number and quality of spontaneous reports submitted to the FDA," concluded lead author Jeffrey Linder, MD, MPH, and colleagues.

An ADE is either an undesired side effect (such as injury, toxicity, or sensitivity reaction), or the failure to perform as expected, whether or not determined to be attributable to the drug.

Related Links:

Massachusetts General Hospital
Brigham & Women's Hospital


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Flocked Fiber Swabs
Puritan® patented HydraFlock®
New
Venous Vascular Closure System
VASCADE MVP
New
Portable Color Doppler Ultrasound Scanner
DCU10

Print article

Channels

Critical Care

view channel
Image: The microfluidic chip analyzes the chemotactic migration behaviors of neutrophils in sepsis patients (Talanta, 2024; DOI: 10.1016/j.talanta.2024.126801)

Microfluidic Chip Method to Improve Sepsis Diagnosis, Progression Evaluation and Prognosis Monitoring

Sepsis, a severe and life-threatening condition, results from an uncontrolled immune response that can lead to multi-organ failure. Given its high mortality rate and the limitations of current diagnostic... Read more

Surgical Techniques

view channel
Image: Illustration of how the razor-sharp flakes of graphene line up together on a surface and can kill bacteria without harming healthy human cells (Photo courtesy of Yen Sandqvist)

Ultra-Thin Graphene-Based Coating Material Paves Way for Bacteria-Killing Medical Devices

Healthcare-associated infections are a significant global issue, leading to immense suffering, increased healthcare costs, and a greater risk of antibiotic resistance. These infections often occur when... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Point of Care

view channel
The Atellica VTLi Patient-side Immunoassay Analyzer, a high-sensitivity troponin I test at the bedside, delivers accurate results in just 8 minutes (Photo courtesy of Siemens Healthineers)

New 8-Minute Blood Test to Diagnose or Rule Out Heart Attack Shortens ED Stay

Emergency department overcrowding is a significant global issue that leads to increased mortality and morbidity, with chest pain being one of the most common reasons for hospital admissions.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.